These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 36909157)

  • 1. Extracellular vesicles mediate biological information delivery: A double-edged sword in cardiac remodeling after myocardial infarction.
    Cheng P; Wang X; Liu Q; Yang T; Qu H; Zhou H
    Front Pharmacol; 2023; 14():1067992. PubMed ID: 36909157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface engineering enhances the therapeutic potential of systemically delivered extracellular vesicles following acute myocardial infarction.
    Mentkowski KI; Tarvirdizadeh T; Manzanero CA; Eagler LA; Lang JK
    FASEB J; 2024 Sep; 38(18):e70070. PubMed ID: 39301939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles - mediating and delivering cardioprotection in acute myocardial infarction and heart failure.
    Prakash A; Crespo-Avilan GE; Hernandez-Resendiz S; Ong SG; Hausenloy DJ
    Cond Med; 2020 Aug; 3(4):227-238. PubMed ID: 34296067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles derived from myocardial infarction plasma inhibit BMSCs apoptosis and enhance cardiac function via AKT signaling pathway.
    Jin P; Ding L; Wang L; Jiang S; Weng J; Gao Y; Fan J; Sun LZ
    Int Immunopharmacol; 2021 Jul; 96():107730. PubMed ID: 34020395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction.
    Turkieh A; Beseme O; Saura O; Charrier H; Michel JB; Amouyel P; Thum T; Bauters C; Pinet F
    J Transl Med; 2024 Jan; 22(1):31. PubMed ID: 38184604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Inflammation after Myocardial Infarction: A Therapeutic Opportunity for Extracellular Vesicles?
    Viola M; de Jager SCA; Sluijter JPG
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cell-Derived Extracellular Vesicle-Shuttled microRNA-302d-3p Represses Inflammation and Cardiac Remodeling Following Acute Myocardial Infarction.
    Liu Y; Guan R; Yan J; Zhu Y; Sun S; Qu Y
    J Cardiovasc Transl Res; 2022 Aug; 15(4):754-771. PubMed ID: 35194734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicle-Based Therapeutics for Heart Repair.
    Saludas L; Oliveira CC; Roncal C; Ruiz-Villalba A; Prósper F; Garbayo E; Blanco-Prieto MJ
    Nanomaterials (Basel); 2021 Feb; 11(3):. PubMed ID: 33668836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of MicroRNA-200b-3p Encapsulated by Mesenchymal Stem Cells-Secreted Extracellular Vesicles in Myocardial Infarction Via Regulating BCL2L11.
    Wan J; Lin S; Yu Z; Song Z; Lin X; Xu R; Du S
    J Am Heart Assoc; 2022 Jun; 11(12):e024330. PubMed ID: 35699193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction.
    Song Y; Zhang C; Zhang J; Jiao Z; Dong N; Wang G; Wang Z; Wang L
    Theranostics; 2019; 9(8):2346-2360. PubMed ID: 31149048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effector cells and cellular mediators of immune system involved in cardiac inflammation and fibrosis after myocardial infarction.
    Liu Y; Xu J; Wu M; Kang L; Xu B
    J Cell Physiol; 2020 Dec; 235(12):8996-9004. PubMed ID: 32352172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicle-Mediated Immune Regulation of Tissue Remodeling and Angiogenesis After Myocardial Infarction.
    Sánchez-Alonso S; Alcaraz-Serna A; Sánchez-Madrid F; Alfranca A
    Front Immunol; 2018; 9():2799. PubMed ID: 30555478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.
    Firoozi S; Pahlavan S; Ghanian MH; Rabbani S; Barekat M; Nazari A; Pakzad M; Shekari F; Hassani SN; Moslem F; Lahrood FN; Soleimani M; Baharvand H
    Biochem Biophys Res Commun; 2020 Apr; 524(4):903-909. PubMed ID: 32057366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
    Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
    Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction.
    Garbayo E; Ruiz-Villalba A; Hernandez SC; Saludas L; Abizanda G; Pelacho B; Roncal C; Sanchez B; Palacios I; Prósper F; Blanco-Prieto MJ
    Acta Biomater; 2021 May; 126():394-407. PubMed ID: 33716175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-Cardiac Release of Extracellular Vesicles Shapes Inflammation Following Myocardial Infarction.
    Loyer X; Zlatanova I; Devue C; Yin M; Howangyin KY; Klaihmon P; Guerin CL; Kheloufi M; Vilar J; Zannis K; Fleischmann BK; Hwang DW; Park J; Lee H; Menasché P; Silvestre JS; Boulanger CM
    Circ Res; 2018 Jun; 123(1):100-106. PubMed ID: 29592957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Changes in Extracellular Vesicle Hemostatic Protein Composition Predict Favourable Left Ventricular Remodeling after Acute Myocardial Infarction.
    Lim XC; Huang C; Yatim SMJM; Chong SY; Tan SH; Yang X; Heldt CL; Pedersen J; Talanker M; Modh H; Wacker MG; Pastorin G; Chan SP; Richards AM; Charles CJ; Chan MY; Wang JW
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis.
    Wu Q; Wang J; Tan WLW; Jiang Y; Wang S; Li Q; Yu X; Tan J; Liu S; Zhang P; Tiang Z; Chen Z; Foo RS; Yang HT
    Cell Death Dis; 2020 May; 11(5):354. PubMed ID: 32393784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective increase of cardiomyocyte derived extracellular vesicles after experimental myocardial infarction and functional effects on the endothelium.
    Rodriguez JA; Orbe J; Saenz-Pipaon G; Abizanda G; Gebara N; Radulescu F; Azcarate PM; Alonso-Perez L; Merino D; Prosper F; Paramo JA; Roncal C
    Thromb Res; 2018 Oct; 170():1-9. PubMed ID: 30081387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition.
    Huang G; Cheng Z; Hildebrand A; Wang C; Cimini M; Roy R; Lucchese AM; Benedict C; Mallaredy V; Magadum A; Joladarashi D; Thej C; Gonzalez C; Trungcao M; Garikipati VNS; Elrod JW; Koch WJ; Kishore R
    Theranostics; 2022; 12(9):4415-4430. PubMed ID: 35673580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.